OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
1-Year Return
84.31%
This Quarter Return
-14.92%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$497M
AUM Growth
-$184M
(-27%)
Cap. Flow
-$66.2M
Cap. Flow
% of AUM
-13.31%
Top 10 Holdings %
Top 10 Hldgs %
93.04%
Holding
32
New
6
Increased
4
Reduced
9
Closed
4
Top Buys
| 1 |
ARK Innovation ETF
ARKK
|
$16.6M |
| 2 |
GeneDx Holdings
WGS
|
$12.1M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$4.52M |
| 4 |
ImmunityBio
IBRX
|
$2.24M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$813K |
Top Sells
| 1 |
Vir Biotechnology
VIR
|
$36.1M |
| 2 |
Pfizer
PFE
|
$28M |
| 3 |
QuidelOrtho
QDEL
|
$16.5M |
| 4 |
Opko Health
OPK
|
$11.1M |
| 5 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
$3.57M |
Sector Composition
| 1 | Healthcare | 96.56% |
| 2 | Energy | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.1B
| – | – |
0
| – | – |
|
27
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$723M
| – | – |
0
| – | – |
|
|
28
Pfizer
PFE
$140B
| – | – |
-475,000
| Closed | -$28M |
|
29
SPDR S&P 500 ETF Trust
SPY
$662B
| – | – |
0
| – | – |
|
|
30
Vir Biotechnology
VIR
$714M
| – | – |
-861,008
| Closed | -$36.1M |
|
31
XBiotech
XBIT
$90.9M
| – | – |
0
| – | – |
|
|
MOTS
32
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| – | – |
-353
| Closed | -$49K |
|